These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 22877426)

  • 1. Bisphosphonates in the treatment of osteoporosis.
    Diab DL; Watts NB
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):487-506. PubMed ID: 22877426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?
    McClung M
    Clin Obstet Gynecol; 2013 Dec; 56(4):743-8. PubMed ID: 24177063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
    McClung M; Harris ST; Miller PD; Bauer DC; Davison KS; Dian L; Hanley DA; Kendler DL; Yuen CK; Lewiecki EM
    Am J Med; 2013 Jan; 126(1):13-20. PubMed ID: 23177553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of bisphosphonates.
    Orozco C; Maalouf NM
    Rheum Dis Clin North Am; 2012 Nov; 38(4):681-705. PubMed ID: 23137577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Going on a drug holiday?
    Bonnick SL
    J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term risks of bisphosphonate therapy.
    Watts NB
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):523-9. PubMed ID: 25166043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FPIN's clinical inquiries. Risks of bisphosphonate use.
    Scott MA; Meadowcraft L; Skolnik D
    Am Fam Physician; 2013 Nov; 88(10):697, 702. PubMed ID: 24364486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
    Soen S
    Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties.
    Hollick RJ; Reid DM
    Menopause Int; 2011 Jun; 17(2):66-72. PubMed ID: 21693503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
    Brown JP; Morin S; Leslie W; Papaioannou A; Cheung AM; Davison KS; Goltzman D; Hanley DA; Hodsman A; Josse R; Jovaisas A; Juby A; Kaiser S; Karaplis A; Kendler D; Khan A; Ngui D; Olszynski W; Ste-Marie LG; Adachi J
    Can Fam Physician; 2014 Apr; 60(4):324-33. PubMed ID: 24733321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate holidays.
    Reid IR
    Drug Ther Bull; 2021 Mar; 59(3):35-36. PubMed ID: 33627350
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of bisphosphonates in older adults: how long is long enough?
    Dunn RL; Bird ML; Conway SE; Stratton MA
    Consult Pharm; 2013 Jan; 28(1):39-57. PubMed ID: 23315281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T
    Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of drug holidays in women taking bisphosphonates.
    Diab DL; Watts NB
    Menopause; 2014 Feb; 21(2):195-7. PubMed ID: 23921518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
    Cole RE
    Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
    Hanley DA; McClung MR; Davison KS; Dian L; Harris ST; Miller PD; Lewiecki EM; Kendler DL;
    Am J Med; 2017 Jul; 130(7):862.e1-862.e7. PubMed ID: 28359721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.
    Reid IR
    Skeletal Radiol; 2011 Sep; 40(9):1191-6. PubMed ID: 21847749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.